Edwards Lifesciences:
Date: | Monday 9 October |
Time: | 12:45-14:00 |
Room: | E1 |
THE NEW INSPIRIS RESILIA AORTIC VALVE: CURRENT EVIDENCE AND ITS EARLY CLINICAL APPLICATION
Chairs: | O. Wendler, King’s College Hospital, London, UK – A. Diegeler, Herz- und Gefäßklinik in Bad Neustadt, Germany |
WHAT’S NEW ABOUT THE NEW EUROPEAN AND AMERICAN GUIDELINES? | Anno Diegeler, Herz- und Gefäßklinik in Bad Neustadt, Germany |
EPIDEMIOLOGY AND CURRENT TREATMENT OPTIONS IN YOUNGER PATIENTS | Ruggero De Paulis, European Hospital, Rome Italy |
RESILIA TISSUE: 2-YEAR CLINICAL SAFETY TRIALS UPDATE | David Heimonsohn, St. Vincent Heart Center of Indiana, US |
REAL-LIFE CLINICAL DECISION MAKING with INSPIRIS RESILIA | Olaf Wendler, King’s College Hospital, London, UK |